Merck's Zetia Arguments Don't Misuse Privilege, Judge Says
By Bryan Koenig ( August 16, 2022, 9:27 PM EDT) -- A Virginia federal judge will allow Merck to make certain arguments about how its executives interpreted a patent litigation settlement with rival drugmaker Glenmark over cholesterol drug Zetia despite claims from antitrust plaintiffs that the company previously made the information off-limits by claiming it's privileged attorney-client communication....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.